JPH04230223A - ソマトスタチン吸収改善医薬組成物、その製法および用途 - Google Patents

ソマトスタチン吸収改善医薬組成物、その製法および用途

Info

Publication number
JPH04230223A
JPH04230223A JP3143095A JP14309591A JPH04230223A JP H04230223 A JPH04230223 A JP H04230223A JP 3143095 A JP3143095 A JP 3143095A JP 14309591 A JP14309591 A JP 14309591A JP H04230223 A JPH04230223 A JP H04230223A
Authority
JP
Japan
Prior art keywords
somatostatin
acid
composition according
formula
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3143095A
Other languages
English (en)
Japanese (ja)
Inventor
Gerd Fricker
ゲルト・フリッカー
Jacky Vonderscher
ジャッキー・フォンデルシェール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPH04230223A publication Critical patent/JPH04230223A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
JP3143095A 1990-06-15 1991-06-14 ソマトスタチン吸収改善医薬組成物、その製法および用途 Pending JPH04230223A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909013448A GB9013448D0 (en) 1990-06-15 1990-06-15 Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
GB9013448 1990-06-15

Publications (1)

Publication Number Publication Date
JPH04230223A true JPH04230223A (ja) 1992-08-19

Family

ID=10677720

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3143095A Pending JPH04230223A (ja) 1990-06-15 1991-06-14 ソマトスタチン吸収改善医薬組成物、その製法および用途

Country Status (21)

Country Link
EP (1) EP0462071B1 (enExample)
JP (1) JPH04230223A (enExample)
KR (1) KR920000323A (enExample)
AU (1) AU7833191A (enExample)
CA (1) CA2044511A1 (enExample)
CH (1) CH683069A5 (enExample)
DE (1) DE4119062A1 (enExample)
ES (1) ES2067906T3 (enExample)
FI (1) FI912868A7 (enExample)
FR (1) FR2663227B1 (enExample)
GB (2) GB9013448D0 (enExample)
HU (1) HUT59007A (enExample)
IE (1) IE912010A1 (enExample)
IL (1) IL98477A0 (enExample)
IT (1) IT1297205B1 (enExample)
LU (1) LU87952A1 (enExample)
NO (1) NO912271L (enExample)
NZ (1) NZ238522A (enExample)
PT (1) PT97964A (enExample)
TW (1) TW226332B (enExample)
ZA (1) ZA914583B (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003818A1 (en) * 1993-07-30 1995-02-09 Teijin Limited Powder for nasal administration of peptidic or proteinaceous drug
WO1997006813A1 (en) * 1995-08-15 1997-02-27 Asahi Kasei Kogyo Kabushiki Kaisha Mucosal preparation containing physiologically active peptide
WO2003037256A3 (en) * 2001-11-01 2004-01-08 Charles W Young Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation
JP2009517409A (ja) * 2005-12-01 2009-04-30 フリンダーズ テクノロジーズ ピーティワイ リミテッド 膵炎を予防および／または治療するための方法および組成物

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9203769D0 (en) * 1992-02-21 1992-04-08 Sandoz Ltd Improvements in or relating to organic compounds
GB9417524D0 (en) * 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
NZ522036A (en) * 2000-04-19 2004-04-30 Borody Thomas J Compositions and therapies for hyperlipidaemia-associated disorders
AU2006314444C1 (en) * 2005-11-21 2018-01-04 Novartis Ag Neuroendocrine tumor treatment using mTOR inhibitors
HRP20170929T1 (hr) 2008-09-17 2017-09-22 Chiasma Inc. Farmaceutski pripravci i odgovarajući postupci za isporuku
GB0817969D0 (en) 2008-10-01 2008-11-05 Axcess Ltd Pharmaceutical composition
AU2016215350B2 (en) 2015-02-03 2021-11-25 Amryt Endo, Inc. Method of treating diseases
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
HU198626B (en) * 1986-05-27 1989-11-28 Sandoz Ag Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient
JPS632932A (ja) * 1986-06-23 1988-01-07 Teijin Ltd 経鼻投与用粉末状組成物
HU203204B (en) * 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003818A1 (en) * 1993-07-30 1995-02-09 Teijin Limited Powder for nasal administration of peptidic or proteinaceous drug
WO1997006813A1 (en) * 1995-08-15 1997-02-27 Asahi Kasei Kogyo Kabushiki Kaisha Mucosal preparation containing physiologically active peptide
WO2003037256A3 (en) * 2001-11-01 2004-01-08 Charles W Young Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation
JP2009517409A (ja) * 2005-12-01 2009-04-30 フリンダーズ テクノロジーズ ピーティワイ リミテッド 膵炎を予防および／または治療するための方法および組成物

Also Published As

Publication number Publication date
LU87952A1 (fr) 1993-01-15
ITRM910430A1 (it) 1992-12-17
FI912868A0 (fi) 1991-06-13
GB9112509D0 (en) 1991-07-31
ITRM910430A0 (it) 1991-06-17
AU7833191A (en) 1992-01-02
NO912271L (no) 1991-12-16
CH683069A5 (de) 1994-01-14
TW226332B (enExample) 1994-07-11
CA2044511A1 (en) 1991-12-16
NO912271D0 (no) 1991-06-13
ZA914583B (en) 1993-02-24
FI912868L (fi) 1991-12-16
FR2663227A1 (fr) 1991-12-20
ES2067906T3 (es) 1995-04-01
HU911849D0 (en) 1991-12-30
IT1297205B1 (it) 1999-08-03
NZ238522A (en) 1993-10-26
GB2244918A (en) 1991-12-18
IL98477A0 (en) 1992-07-15
GB9013448D0 (en) 1990-08-08
HUT59007A (en) 1992-04-28
GB2244918B (en) 1994-06-15
PT97964A (pt) 1992-03-31
EP0462071A1 (en) 1991-12-18
DE4119062A1 (de) 1991-12-19
FR2663227B1 (fr) 1995-04-28
FI912868A7 (fi) 1991-12-16
EP0462071B1 (en) 1995-02-01
IE912010A1 (en) 1991-12-18
KR920000323A (ko) 1992-01-29

Similar Documents

Publication Publication Date Title
JP5042312B2 (ja) Ｈｇｈを含む経口送達用医薬組成物
US7423014B2 (en) Insulin conjugates for treating diabetes mellitus
KR930003332B1 (ko) 항이뇨제 ddavp의 경구 투여용 제제의 제조방법
KR101070036B1 (ko) 골관절염에 대한 칼시토닌의 용도
CN1178696C (zh) 含人体生长激素和皮质甾醇合成抑制剂的用于治疗代谢综合症的制剂
JPH11508606A (ja) 経口用ペプチド薬剤
BRPI0610091B1 (pt) Análogo de peptídeo 2 tipo glucagon (glp-2), composição farmacêutica, uso de um análogo de glp-2, e, kit terapêutico
BRPI0908292B1 (pt) Métodos e composições para administração oral de exenatida
CA2115377A1 (en) Therapeutic agent for digestive tract diseases
JPH04230223A (ja) ソマトスタチン吸収改善医薬組成物、その製法および用途
US5393738A (en) Pharmaceutical compositions containing octreotide and excipients for oral or rectal administration
JP2809707B2 (ja) 関節炎の処置
JPH06345665A (ja) 生理学的に活性なペプチドを含有する膣投与製剤
US5068221A (en) Treatment of motility disorders with a gnrh analog
US5166192A (en) Treatment of motility disorders with a GnRH analog
JPH10226650A (ja) グリチルリチン経口投与製剤
KR20250010185A (ko) 역마이셀 약물 전달체 및 이를 포함하는 경구용 약학적 조성물
CN1966072A (zh) 一种降钙素口服肠溶组合物及其制备方法
TWI228992B (en) Treatment of subnormal bone mineral density
FR2668933A1 (fr) Composition pharmaceutique a base de somatostatine.
JPH0149130B2 (enExample)
JPWO2002028398A1 (ja) 糖尿病治療用組成物
HK76091A (en) Ddavp antidiuretic and method therefor